anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 68,941-68,970
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

68,941-68,970 of 96,741

filter-aware
01
Slide 1
Kerrisdale Capital research note; long position disclosure.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
03
The text discusses the clinical problem of persistent AF and the technical limitations of existing contact mapping systems like CARTO.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
04
The slide uses a 'before-after' framing (traditional vs. AcQMap) to establish the superiority of the AcQMap technology.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
05
This is a research note from Kerrisdale Capital regarding Acutus Medical. It argues that past performance issues were temporary and are now resolved.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
06
Kerrisdale Capital research note page 6.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
09
The slide uses a medical illustration to explain the mechanism of action for a surgical procedure.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
10
This is a text-heavy research note page detailing medical trial outcomes and procedural methodologies.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
11
The slide serves as a critical analysis of current medical standards, positioning Acutus as a solution to the identified clinical void.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
12
The slide serves as a technical primer to establish the baseline technology before contrasting it with Acutus's solution.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
13
This is a text-heavy research note page from Kerrisdale Capital, focusing on the technical flaws of current contact-based mapping technologies in cardiac ablation.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
14
The slide is a text-heavy research note from Kerrisdale Capital critiquing current medical technology.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
15
The slide highlights the technological superiority of AcQMap's non-contact charge-density mapping over traditional contact mapping methods.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
16
The slide uses a medical imaging sequence to demonstrate the technological superiority of the AcQMap system over Acutus's legacy mapping.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
17
The slide uses clinical trial results as evidence to support the investment thesis regarding the efficacy of the AcQMap technology.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
18
The slide discusses a specific clinical study led by Betts and Wong, contrasting its methodology and outcomes with the UNCOVER trial.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
20
The text highlights specific time-saving metrics (10-15 mins vs 3 mins) and workflow advantages (multiple remappings).Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
21
This is a text-heavy research note slide summarizing qualitative feedback from Electrophysiologists (EPs).Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
23
This is a standard text-heavy page from a research report rather than a presentation slide.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
24
The slide uses a narrative structure to explain a past financial performance dip while projecting future market growth for Acutus Medical.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
25
This is a text-heavy research note page detailing the 'stumbles' of Acutus Medical and the subsequent resolution of these issues.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
26
This is a standard text-heavy research report page rather than a traditional presentation slide.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
27
This is a text-heavy research note slide summarizing the investment case.Acutus Medical Inc. (AFIB) · Kerrisdale Capital
Research note Short seller 1 hit
21
The slide argues that CareDx effectively monetized the research process itself, creating a conflict of interest and a circular revenue model.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Beat · Thesis HeadlineLoop · Cost Of Inaction1 hit
22
The slide uses a footnote to perform a 'gap analysis' between management's cumulative patient claims and the quarterly growth figures.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Loop · Cost Of Inaction1 hit
23
This is a research note page from Kerrisdale Capital, focusing on competitive analysis and product obsolescence.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Loop · Cost Of Inaction1 hit
24
The slide discusses the impact of PAMA rules on Medicare reimbursement and the potential for price competition between Natera and CareDx.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Loop · Cost Of Inaction1 hit
25
This is a research note from Kerrisdale Capital criticizing CareDx's market sizing methodology.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Loop · Cost Of Inaction1 hit
26
This is a text-heavy research note page from a Kerrisdale Capital report.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller Loop · Cost Of Inaction1 hit
27
The slide uses a 'Valuing CareDx like Natera' comparison to justify a -70% downside estimate.CareDx, Inc. (CDNA) · Kerrisdale Capital
Research note Short seller 1 hit
01
Slide 1
The slide functions as a classic short-seller research note introduction, establishing the thesis and the firm's position.Digital World Acquisition Corp (DWAC) · Kerrisdale Capital
Research note Short seller Beat · Problem & Complication1 hit